Tags

Type your tag names separated by a space and hit enter

Prevalence and correlates of postabortion long-acting reversible contraceptive (LARC) use among young women (24 and below) in Nepal: Strategy in the search for improvements.
Reprod Health 2019; 16(1):55RH

Abstract

INTRODUCTION

Postabortion contraceptive use differs across countries, suggesting the need for country-level research to identify barriers and suggest appropriate interventions. This study aimed to identify the prevalence and correlates of postabortion long-acting reversible contraceptive (LARC) use among women aged 24 or younger in Nepal.

METHODS

This is a cohort study using Health Management Information System (HMIS) data where individual case records of women seeking induced abortion or postabortion care were documented using structured HMIS 3.7 records. Analysis was performed on the individual case records of 20,307 women 24 years or younger who received induced abortion or postabortion care services in the three-year period from July 2014 to June 2017 at 433 public and private health facilities.

FINDINGS

Overall, LARC uptake during the study period was 11% (IUD: 3% and implant: 8%). The odds of LARC acceptance was higher for young women (24 and below) who belonged to Brahmin/Chhetri (AOR = 1.23; 95% CI: 1.02-1.47) and Janajatis (AOR = 1.20; 95% CI: 1.01-1.43) as compared to Dalits; young women who had an induced abortion (AOR = 3.75; 95% CI: 1.75-8.06) compared with postabortion care; and those receiving service from public sector health facilities (AOR = 4.00; 95% CI: 2.06-7.75) compared with private sector health facilities.

CONCLUSION

The findings from this study indicate the need to focus on barriers to acceptance of LARC among several groups of young women (24 and below) receiving abortion care in Nepal: Dalits, Madhesis and Muslims; nulliparous women; and those receiving services at private sector health facilities.

Authors+Show Affiliations

Ipas Nepal, Baluwatar, Do Cha Marg, Ward No.: 04, Kathmandu, 44600, Nepal. Ministry of Health, Ram Shah Path, Kathmandu, 44600, Nepal.Ipas Nepal, Baluwatar, Do Cha Marg, Ward No.: 04, Kathmandu, 44600, Nepal.Ipas, P.O. Box 9990, Chapel Hill, NC, 27515, USA.Ipas Nepal, Baluwatar, Do Cha Marg, Ward No.: 04, Kathmandu, 44600, Nepal.Institute of Medicine, Kathmandu, Nepal.Ipas, P.O. Box 9990, Chapel Hill, NC, 27515, USA.Ministry of Health, Ram Shah Path, Kathmandu, 44600, Nepal.Ipas Nepal, Baluwatar, Do Cha Marg, Ward No.: 04, Kathmandu, 44600, Nepal.Ipas, P.O. Box 9990, Chapel Hill, NC, 27515, USA. andersenk@ipas.org.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31088518

Citation

Mehata, Suresh, et al. "Prevalence and Correlates of Postabortion Long-acting Reversible Contraceptive (LARC) Use Among Young Women (24 and Below) in Nepal: Strategy in the Search for Improvements." Reproductive Health, vol. 16, no. 1, 2019, p. 55.
Mehata S, Bhattarai N, Menzel J, et al. Prevalence and correlates of postabortion long-acting reversible contraceptive (LARC) use among young women (24 and below) in Nepal: Strategy in the search for improvements. Reprod Health. 2019;16(1):55.
Mehata, S., Bhattarai, N., Menzel, J., Shah, M., Khanal, P., Tofigh, S., ... Andersen, K. (2019). Prevalence and correlates of postabortion long-acting reversible contraceptive (LARC) use among young women (24 and below) in Nepal: Strategy in the search for improvements. Reproductive Health, 16(1), p. 55. doi:10.1186/s12978-019-0708-7.
Mehata S, et al. Prevalence and Correlates of Postabortion Long-acting Reversible Contraceptive (LARC) Use Among Young Women (24 and Below) in Nepal: Strategy in the Search for Improvements. Reprod Health. 2019 May 14;16(1):55. PubMed PMID: 31088518.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevalence and correlates of postabortion long-acting reversible contraceptive (LARC) use among young women (24 and below) in Nepal: Strategy in the search for improvements. AU - Mehata,Suresh, AU - Bhattarai,Navaraj, AU - Menzel,Jamie, AU - Shah,Mukta, AU - Khanal,Pratik, AU - Tofigh,Shadie, AU - Khanal,Mukti Nath, AU - Regmi,Shibesh Chandra, AU - Andersen,Kathryn, Y1 - 2019/05/14/ PY - 2018/07/03/received PY - 2019/04/11/accepted PY - 2019/5/16/entrez PY - 2019/5/16/pubmed PY - 2019/6/25/medline KW - Health management information system KW - Induced abortion KW - Long-acting reversible contraceptives KW - Nepal KW - Postabortion care SP - 55 EP - 55 JF - Reproductive health JO - Reprod Health VL - 16 IS - 1 N2 - INTRODUCTION: Postabortion contraceptive use differs across countries, suggesting the need for country-level research to identify barriers and suggest appropriate interventions. This study aimed to identify the prevalence and correlates of postabortion long-acting reversible contraceptive (LARC) use among women aged 24 or younger in Nepal. METHODS: This is a cohort study using Health Management Information System (HMIS) data where individual case records of women seeking induced abortion or postabortion care were documented using structured HMIS 3.7 records. Analysis was performed on the individual case records of 20,307 women 24 years or younger who received induced abortion or postabortion care services in the three-year period from July 2014 to June 2017 at 433 public and private health facilities. FINDINGS: Overall, LARC uptake during the study period was 11% (IUD: 3% and implant: 8%). The odds of LARC acceptance was higher for young women (24 and below) who belonged to Brahmin/Chhetri (AOR = 1.23; 95% CI: 1.02-1.47) and Janajatis (AOR = 1.20; 95% CI: 1.01-1.43) as compared to Dalits; young women who had an induced abortion (AOR = 3.75; 95% CI: 1.75-8.06) compared with postabortion care; and those receiving service from public sector health facilities (AOR = 4.00; 95% CI: 2.06-7.75) compared with private sector health facilities. CONCLUSION: The findings from this study indicate the need to focus on barriers to acceptance of LARC among several groups of young women (24 and below) receiving abortion care in Nepal: Dalits, Madhesis and Muslims; nulliparous women; and those receiving services at private sector health facilities. SN - 1742-4755 UR - https://www.unboundmedicine.com/medline/citation/31088518/Prevalence_and_correlates_of_postabortion_long_acting_reversible_contraceptive__LARC__use_among_young_women__24_and_below__in_Nepal:_Strategy_in_the_search_for_improvements_ L2 - https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-019-0708-7 DB - PRIME DP - Unbound Medicine ER -